EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn’s Disease: A Waitlist Control Pilot Trial

Jessica K Salwen-Deremer iD, Sarah J Westvold, Kelly Aschbrenner, Michael T Smith, Corey A Siegel iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf210 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Jessica K Salwen-Deremer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Sleep Initiation and Maintenance Disorders, Crohn Disease, Pain Management. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, CCF, Buhlmann Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Poor sleep is common in Crohn’s disease (CD), prospectively predicts worse disease course, and is often attributable to insomnia. Cognitive behavioral therapy for insomnia (CBT-I) is the recommended treatment for chronic insomnia disorder. CBT-I improves sleep and may improve pain intensity, pain interference, and inflammation. We sought to investigate whether CBT-I impacts these factors in patients with active CD.

Method

We recruited patients with insomnia and mild-to-moderate CD symptoms from an inflammatory bowel disease center. Exclusion criteria were other sleep disorders, significant psychiatric concerns, and presence of other common influences on sleep. Participants completed baseline assessments of sleep, pain, and inflammation then were randomized to receive CBT-I immediately, or wait 12 weeks and then repeat the baseline assessment and complete CBT-I. Similar assessments occurred immediately post–CBT-I and 1 month later. CBT-I included sleep restriction, stimulus control, sleep hygiene, arousal reduction, and cognitive therapy.

Results

A total of 26 participants completed the study. In group × time analyses, CBT-I led to greater reductions in insomnia severity (P < .001) and wake after sleep onset (P = .02) than waitlist. In pre- to post-treatment analyses, participants reported significant improvements in subjective measures of sleep continuity, CD symptom severity, pain intensity, and pain interference. C-reactive protein trended toward improvement.

Discussion

This study provides preliminary evidence of efficacy of CBT-I in people with CD. CBT-I improved self-reported sleep and may improve pain and CD symptoms. The results highlight the importance of addressing sleep concerns in inflammatory bowel disease, particularly in people with persistent pain or fatigue. Future trials powered to detect changes in pain and inflammation are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Behavioral TherapySleep Initiation and Maintenance DisordersCrohn DiseasePain ManagementPainHumansFemaleMalePilot ProjectsAdultMiddle AgedWaiting ListsTreatment Outcome

Stichwörter der Autor:innen

clinical trialinflammatory bowel diseaseinsomniapainpsychogastroenterology

Autor:innen und Institutionen

  • Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
  • Section of Gastroenterology and Hepatology, Center for Digestive Health, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
  • Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
  • Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, NH, United States.
  • Department of Psychology and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States.

ORCID-Profile: Jessica K Salwen-Deremer, Corey A Siegel

Förderung

  • NIDDK NIH HHS
  • CCF
  • Buhlmann Diagnostics
  • Crohn’s & Colitis Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Salwen-Deremer, J. K., Westvold, S. J., Aschbrenner, K., Smith, M. T., & Siegel, C. A. (2026). Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn’s Disease: A Waitlist Control Pilot Trial. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf210

Vancouver

Salwen-Deremer JK, Westvold SJ, Aschbrenner K, Smith MT, Siegel CA. Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn’s Disease: A Waitlist Control Pilot Trial. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf210

BibTeX
@article{SalwenDeremer2026,
  author = {Salwen-Deremer, Jessica K and Westvold, Sarah J and Aschbrenner, Kelly and Smith, Michael T and Siegel, Corey A},
  title = {Cognitive Behavioral Therapy for Insomnia May Improve Sleep and Pain in Crohn’s Disease: A Waitlist Control Pilot Trial},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf210}
}
Kostenlos starten →